The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Ankylosing Spondylitis Global Market Report 2024, the ankylosing spondylitis market is expected to show significant growth in the forecast period.

Ankylosing Spondylitis Market: A Thriving Industry
The ankylosing spondylitis market size has witnessed a robust expansion in recent years. The market soared from $5.41 billion in 2023 to $5.86 billion in 2024, showcasing a compound annual growth rate (CAGR) of 8.4%. The growth trajectory in the historic period can be attributed to several key factors:

• Discovery of HLA-B27
• Development of biologic treatments
• Advancements in pain management approaches
• Rising patient advocacy and awareness
• Introduction of NSAIDs and disease-modifying drugs

A Glimpse into the Future: Growth Projections
Projections suggest that the ankylosing spondylitis market will continue its upward trajectory, reaching $7.89 billion by 2028, with a CAGR of 7.7% in the forecast period. Anticipated growth drivers in the forecast period include:

• Personalized medicine approaches
• Development of novel biologics
• Emphasis on early intervention and screening
• Focus on lifestyle and diet management
• Integration of telemedicine and remote monitoring

Major Trends Shaping the Landscape
The forecast period introduces several notable trends that are expected to reshape the ankylosing spondylitis market:

• Availability of biosimilars
• Emergence of targeted pain therapies
• Emphasis on patient-reported outcomes (PROs)
• Expansion of community support programs
• Exploration of regenerative medicine

View More On The Ankylosing Spondylitis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ankylosing-spondylitis-global-market-report

Ankylosing Spondylitis Market Surges With the Growing Geriatric Population Worldwide
The escalating geriatric population globally serves as a significant catalyst for the expansion of the ankylosing spondylitis market. This demographic shift, characterized by an increase in the proportion of elderly individuals, has propelled the demand for ankylosing spondylitis treatments and drugs. Key statistics underline this trend:

• By 2030, 1 out of 6 people globally will be aged 60 years or above.
• In 2020, the number of elderly individuals surpassed 1 billion, reaching 1.4 billion.

Advancements in Therapeutic Options Drive Growth
The market is witnessing a surge in advancements in therapeutic options, spearheaded by key players striving to maintain their competitive edge. Noteworthy developments include:

• FDA approval for XELJANZ (tofacitinib) by Pfizer Inc. for the treatment of active ankylosing spondylitis.
• Merck & Co. Inc.’s acquisition of Prometheus Biosciences Inc., broadening its immunology pipeline.

Segmentation and Regional Dynamics
The ankylosing spondylitis market is segmented based on various parameters, including treatment type, molecule, route of administration, application, and end-user.

1. Treatment Type:
   • Painkillers and NSAIDs
   • DMARDs
   • Biological Therapies
   • Steroids
   • Physical Therapies
   • Surgery
2. Molecule:
   • Biologics
   • Biosimilar
   • Small Molecules
3. Route of Administration:
   • Parenteral
   • Oral
   • Other Routes
4. Application:
   • Juveniles
   • Adults
5. End User:
   • Hospitals
   • Clinics
   • Research Laboratories
   • Other End Users

Regional Insights:

• North America led the market in 2023.
• Asia-Pacific is poised to emerge as the fastest-growing region in the forecast period.

In conclusion, the ankylosing spondylitis market is experiencing significant growth, driven by demographic shifts, advancements in therapeutic options, and evolving market dynamics. As key players continue to innovate and expand their portfolios, the landscape of ankylosing spondylitis treatment is poised for remarkable transformations in the years ahead.

Request A Sample Of The Global Ankylosing Spondylitis Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=11962&type=smp